Q&A

In this Q&A, Dr Craig Chepke discusses some new and emerging treatments for MDD that he is particularly excited about.

In part 2 of this interview, Estelle Everett, MD, addresses the shortage of endocrinologists from underserved communities and highlights strategies to build a more diverse health care workforce. She also...

In part 1 of this interview, Estelle Everett, MD, explores the impact of provider bias and clinic barriers on access to diabetes technology. She shares how improving access to tools like continuous glucose...

Consolidation therapy with intermediate- to high-dose cytarabine is crucial in the prevention of acute myeloid leukemia relapse. In this Q&A, Kendall Diebold, DNP, FNP-C, answers questions...

Although most of the literature on home insulin pump use currently focuses on adults with type 1 diabetes, Sarah Lawson, MD, and her team recently developed a study that looks at the pediatric population....

In this expert Q&A, lead study author Hyon K. Choi, MD, DrPH, discusses his team's study examining the association between serum urate levels and the rate of recurrent gout flares among patients with a...

In this Q and A, Valentina Celoria, MD, discusses the relationship between the human microbiome and psoriatic disease, as well as what this relationship may mean for future treatments.

Jennifer Walsh, DNP, CPNP, CNE, talks about the reasons for the sudden surge in measles cases in the United States, what clinicians can do to make their patients aware of the increase, and the potential...

In this Q and A, Nader Shaik, MD, MPH, discusses the results of his team's recent study examining treatment failure rates of short-course vs standard-course antimicrobial therapy for the treatment of...

In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...